Once-weekly Versus Twice-weekly Carfilzomib in Combination With Dexamethasone in Adults With Relapsed and Refractory Multiple Myeloma
Clinical trial NCT02412878 · COMPLETED
Trial details
- NCT number
- NCT02412878
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-09
- Primary completion
- 2017-06-15
- Enrollment
- 478
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.